D.E. Shaw & Co’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-54,517
| Closed | -$116K | – | 3025 |
|
|
2024
Q4 | $116K | Sell |
54,517
-35,808
| -40% | -$76.3K | ﹤0.01% | 2793 |
|
|
2024
Q3 | $253K | Sell |
90,325
-149,930
| -62% | -$420K | ﹤0.01% | 2749 |
|
|
2024
Q2 | $560K | Buy |
240,255
+44,477
| +23% | +$104K | ﹤0.01% | 2439 |
|
|
2024
Q1 | $875K | Buy |
195,778
+120,138
| +159% | +$537K | ﹤0.01% | 2170 |
|
|
2023
Q4 | $243K | Sell |
75,640
-48,598
| -39% | -$156K | ﹤0.01% | 2628 |
|
|
2023
Q3 | $394K | Sell |
124,238
-151,610
| -55% | -$481K | ﹤0.01% | 2385 |
|
|
2023
Q2 | $1.37M | Sell |
275,848
-236,828
| -46% | -$1.18M | ﹤0.01% | 1941 |
|
|
2023
Q1 | $2.53M | Sell |
512,676
-147,511
| -22% | -$729K | ﹤0.01% | 1722 |
|
|
2022
Q4 | $4.15M | Buy |
660,187
+220,492
| +50% | +$1.39M | ﹤0.01% | 1568 |
|
|
2022
Q3 | $4.75M | Buy |
439,695
+156,004
| +55% | +$1.68M | 0.01% | 1504 |
|
|
2022
Q2 | $3.23M | Sell |
283,691
-701,412
| -71% | -$8M | ﹤0.01% | 1936 |
|
|
2022
Q1 | $8.97M | Buy |
985,103
+455,288
| +86% | +$4.15M | 0.01% | 1189 |
|
|
2021
Q4 | $7.91M | Buy |
529,815
+507,107
| +2,233% | +$7.57M | 0.01% | 1313 |
|
|
2021
Q3 | $584K | Sell |
22,708
-179,555
| -89% | -$4.62M | ﹤0.01% | 2769 |
|
|
2021
Q2 | $5.28M | Buy |
+202,263
| New | +$5.28M | ﹤0.01% | 1399 |
|
|
2020
Q4 | – | Sell |
-6,459
| Closed | -$244K | – | 2702 |
|
|
2020
Q3 | $244K | Buy |
+6,459
| New | +$244K | ﹤0.01% | 2349 |
|
|
2020
Q1 | – | Sell |
-125,030
| Closed | -$3.25M | – | 2644 |
|
|
2019
Q4 | $3.25M | Buy |
+125,030
| New | +$3.25M | ﹤0.01% | 1387 |
|